{"id":"https://openalex.org/W4389948113","doi":"https://doi.org/10.1038/s41386-023-01779-x","title":"TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner","display_name":"TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner","publication_year":2023,"publication_date":"2023-12-19","ids":{"openalex":"https://openalex.org/W4389948113","doi":"https://doi.org/10.1038/s41386-023-01779-x","pmid":"https://pubmed.ncbi.nlm.nih.gov/38110609","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11109157"},"language":"en","primary_location":{"id":"doi:10.1038/s41386-023-01779-x","doi":"https://doi.org/10.1038/s41386-023-01779-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41386-023-01779-x","pdf_url":"https://www.nature.com/articles/s41386-023-01779-x.pdf","source":{"id":"https://openalex.org/S175030738","display_name":"Neuropsychopharmacology","issn_l":"0893-133X","issn":["0893-133X","1740-634X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/s41386-023-01779-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017199191","display_name":"Sung Min Yang","orcid":"https://orcid.org/0000-0003-4318-2011","observed_orcids":["https://orcid.org/0000-0003-4318-2011","https://orcid.org/0000-0001-6057-3458"]},"institutions":[{"id":"https://openalex.org/I4210140088","display_name":"Sumitomo Dainippon Pharma (United States)","ror":"https://ror.org/04vwbmb32","country_code":"US","type":"company","lineage":["https://openalex.org/I31591830","https://openalex.org/I4210140088"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sung M. Yang","raw_affiliation_strings":["Sumitomo Pharma America, Inc., Marlborough, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Pharma America, Inc., Marlborough, MA, USA","institution_ids":["https://openalex.org/I4210140088"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066930252","display_name":"Ayan Ghoshal","orcid":"https://orcid.org/0000-0003-3247-8706","observed_orcids":["https://orcid.org/0000-0003-3247-8706","https://orcid.org/0009-0008-8339-3933"]},"institutions":[{"id":"https://openalex.org/I4210140088","display_name":"Sumitomo Dainippon Pharma (United States)","ror":"https://ror.org/04vwbmb32","country_code":"US","type":"company","lineage":["https://openalex.org/I31591830","https://openalex.org/I4210140088"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayan Ghoshal","raw_affiliation_strings":["Sumitomo Pharma America, Inc., Marlborough, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Pharma America, Inc., Marlborough, MA, USA","institution_ids":["https://openalex.org/I4210140088"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038755487","display_name":"Jeffrey M. Hubbard","orcid":"https://orcid.org/0000-0003-2619-2242","observed_orcids":["https://orcid.org/0000-0003-2619-2242"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey M. Hubbard","raw_affiliation_strings":["Neuroservices Alliance, Le Puy Sainte R\u00e9parade, France"],"raw_orcid":"https://orcid.org/0000-0003-2619-2242","affiliations":[{"raw_affiliation_string":"Neuroservices Alliance, Le Puy Sainte R\u00e9parade, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002395605","display_name":"Florian Gacki\u00e8re","orcid":"https://orcid.org/0009-0009-1837-7176","observed_orcids":["https://orcid.org/0009-0009-1837-7176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Florian Gacki\u00e8re","raw_affiliation_strings":["Neuroservices Alliance, Le Puy Sainte R\u00e9parade, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroservices Alliance, Le Puy Sainte R\u00e9parade, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093531456","display_name":"Romain Teyssi\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Romain Teyssi\u00e9","raw_affiliation_strings":["Neuroservices Alliance, Le Puy Sainte R\u00e9parade, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroservices Alliance, Le Puy Sainte R\u00e9parade, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113623609","display_name":"Stuart A. Neale","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stuart A. Neale","raw_affiliation_strings":["Neurexpert Limited, Newcastle, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurexpert Limited, Newcastle, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063897129","display_name":"Seth C. Hopkins","orcid":"https://orcid.org/0000-0003-3999-2281","observed_orcids":["https://orcid.org/0000-0003-3999-2281"]},"institutions":[{"id":"https://openalex.org/I4210140088","display_name":"Sumitomo Dainippon Pharma (United States)","ror":"https://ror.org/04vwbmb32","country_code":"US","type":"company","lineage":["https://openalex.org/I31591830","https://openalex.org/I4210140088"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seth C. Hopkins","raw_affiliation_strings":["Sumitomo Pharma America, Inc., Marlborough, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-3999-2281","affiliations":[{"raw_affiliation_string":"Sumitomo Pharma America, Inc., Marlborough, MA, USA","institution_ids":["https://openalex.org/I4210140088"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084126298","display_name":"Kenneth S. Koblan","orcid":"https://orcid.org/0000-0001-6103-2629","observed_orcids":["https://orcid.org/0000-0001-6103-2629"]},"institutions":[{"id":"https://openalex.org/I4210140088","display_name":"Sumitomo Dainippon Pharma (United States)","ror":"https://ror.org/04vwbmb32","country_code":"US","type":"company","lineage":["https://openalex.org/I31591830","https://openalex.org/I4210140088"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth S. Koblan","raw_affiliation_strings":["Sumitomo Pharma America, Inc., Marlborough, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Pharma America, Inc., Marlborough, MA, USA","institution_ids":["https://openalex.org/I4210140088"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030640333","display_name":"Linda J. Bristow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140088","display_name":"Sumitomo Dainippon Pharma (United States)","ror":"https://ror.org/04vwbmb32","country_code":"US","type":"company","lineage":["https://openalex.org/I31591830","https://openalex.org/I4210140088"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda J. Bristow","raw_affiliation_strings":["Sumitomo Pharma America, Inc., Marlborough, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Pharma America, Inc., Marlborough, MA, USA","institution_ids":["https://openalex.org/I4210140088"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010290773","display_name":"Nina Dedic","orcid":"https://orcid.org/0009-0000-3769-725X","observed_orcids":["https://orcid.org/0009-0000-3769-725X"]},"institutions":[{"id":"https://openalex.org/I4210140088","display_name":"Sumitomo Dainippon Pharma (United States)","ror":"https://ror.org/04vwbmb32","country_code":"US","type":"company","lineage":["https://openalex.org/I31591830","https://openalex.org/I4210140088"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nina Dedic","raw_affiliation_strings":["Sumitomo Pharma America, Inc., Marlborough, MA, USA. nina.dedic@us.sumitomo-pharma.com","Sumitomo Pharma America, Inc., Marlborough, MA, USA"],"raw_orcid":"https://orcid.org/0009-0000-3769-725X","affiliations":[{"raw_affiliation_string":"Sumitomo Pharma America, Inc., Marlborough, MA, USA. nina.dedic@us.sumitomo-pharma.com","institution_ids":[]},{"raw_affiliation_string":"Sumitomo Pharma America, Inc., Marlborough, MA, USA","institution_ids":["https://openalex.org/I4210140088"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5010290773"],"corresponding_institution_ids":["https://openalex.org/I4210140088"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":{"value":4790,"currency":"USD","value_usd":4790},"fwci":2.1142,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.88553892,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"49","issue":"7","first_page":"1091","last_page":"1103"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.4088999927043915,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.4088999927043915,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.33640000224113464,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.20579999685287476,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ulotaront","display_name":"ulotaront","score":0.9879999756813049},{"id":"https://openalex.org/keywords/taar1-agonists","display_name":"TAAR1 agonists","score":0.8550000190734863},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7129999995231628},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.8579999804496765},{"id":"https://openalex.org/keywords/excitation-inhibition-balance","display_name":"excitation-inhibition balance","score":0.8870000243186951},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":1.0},{"id":"https://openalex.org/keywords/spontaneous-synaptic-activity","display_name":"spontaneous synaptic activity","score":0.6499999761581421},{"id":"https://openalex.org/keywords/dopaminergic-tone","display_name":"dopaminergic tone","score":0.8399999737739563},{"id":"https://openalex.org/keywords/state-dependent-modulation","display_name":"state-dependent modulation","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.9192654490470886},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.7654902935028076},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.6637464165687561},{"id":"https://openalex.org/C2779177108","wikidata":"https://www.wikidata.org/wiki/Q18356742","display_name":"GABAergic","level":3,"score":0.499068021774292},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.49689391255378723},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.47320836782455444},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.4689701795578003},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.44643649458885193},{"id":"https://openalex.org/C112592302","wikidata":"https://www.wikidata.org/wiki/Q1207387","display_name":"Excitatory postsynaptic potential","level":3,"score":0.4380204677581787},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.366820752620697},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32705116271972656},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1870703101158142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16624775528907776},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.13791561126708984},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13207972049713135}],"mesh":[{"descriptor_ui":"D000095383","descriptor_name":"Trace Amine-Associated Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019706","descriptor_name":"Excitatory Postsynaptic Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019706","descriptor_name":"Excitatory Postsynaptic Potentials","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/s41386-023-01779-x","doi":"https://doi.org/10.1038/s41386-023-01779-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41386-023-01779-x","pdf_url":"https://www.nature.com/articles/s41386-023-01779-x.pdf","source":{"id":"https://openalex.org/S175030738","display_name":"Neuropsychopharmacology","issn_l":"0893-133X","issn":["0893-133X","1740-634X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11109157","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11109157","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11109157/pdf/41386_2023_Article_1779.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"Text"},{"id":"pmid:38110609","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38110609","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41386-023-01779-x","doi":"https://doi.org/10.1038/s41386-023-01779-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41386-023-01779-x","pdf_url":"https://www.nature.com/articles/s41386-023-01779-x.pdf","source":{"id":"https://openalex.org/S175030738","display_name":"Neuropsychopharmacology","issn_l":"0893-133X","issn":["0893-133X","1740-634X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311407","display_name":"Sunovion","ror":"https://ror.org/030zc7t66"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389948113.pdf","grobid_xml":"https://content.openalex.org/works/W4389948113.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1579518684","https://openalex.org/W1987248281","https://openalex.org/W2001759117","https://openalex.org/W2007027293","https://openalex.org/W2008639041","https://openalex.org/W2011355421","https://openalex.org/W2012520776","https://openalex.org/W2022961682","https://openalex.org/W2033230112","https://openalex.org/W2070210944","https://openalex.org/W2077622066","https://openalex.org/W2085926691","https://openalex.org/W2093248761","https://openalex.org/W2096681544","https://openalex.org/W2109196233","https://openalex.org/W2120299904","https://openalex.org/W2132634436","https://openalex.org/W2142137999","https://openalex.org/W2145602532","https://openalex.org/W2146809691","https://openalex.org/W2155758917","https://openalex.org/W2159155203","https://openalex.org/W2160695817","https://openalex.org/W2274979321","https://openalex.org/W2463733687","https://openalex.org/W2625233830","https://openalex.org/W2860035592","https://openalex.org/W2900440811","https://openalex.org/W2924529414","https://openalex.org/W2944845898","https://openalex.org/W2948506592","https://openalex.org/W2964999518","https://openalex.org/W2978685810","https://openalex.org/W2982167270","https://openalex.org/W2982685163","https://openalex.org/W3002179283","https://openalex.org/W3014686614","https://openalex.org/W3015204490","https://openalex.org/W3022484871","https://openalex.org/W3082177965","https://openalex.org/W3155391591","https://openalex.org/W3159231782","https://openalex.org/W3213184078","https://openalex.org/W3214974865","https://openalex.org/W4200032489","https://openalex.org/W4200212552","https://openalex.org/W4224935934","https://openalex.org/W4295539761","https://openalex.org/W4308568366","https://openalex.org/W4362455699","https://openalex.org/W4364381254","https://openalex.org/W4384206884","https://openalex.org/W4387743460","https://openalex.org/W4388000631"],"related_works":["https://openalex.org/W4415544573","https://openalex.org/W7169853128","https://openalex.org/W7221429291","https://openalex.org/W7165795154","https://openalex.org/W4200449691","https://openalex.org/W4200032489","https://openalex.org/W4308568366","https://openalex.org/W2068441555","https://openalex.org/W2158648681","https://openalex.org/W7011282920"],"abstract_inverted_index":{"Aberrant":[0],"dopaminergic":[1,50,192],"and":[2,9,23,70,98,106,111,179,194],"glutamatergic":[3,68,103,132,197],"function,":[4],"particularly":[5],"within":[6],"the":[7,16,53,61,67,76,95,128,145,158,173,190],"striatum":[8,97,159],"hippocampus,":[10],"has":[11,33],"repeatedly":[12],"been":[13],"associated":[14,199],"with":[15,144,200],"pathophysiology":[17],"of":[18,49,63,78,177],"schizophrenia.":[19,42,201],"Supported":[20],"by":[21,160],"preclinical":[22],"recent":[24],"clinical":[25,87],"data,":[26],"trace":[27],"amine-associated":[28],"receptor":[29],"1":[30],"(TAAR1)":[31],"agonism":[32],"emerged":[34],"as":[35,52],"a":[36,81,135],"potential":[37],"new":[38],"treatment":[39],"approach":[40],"for":[41,89],"While":[43],"current":[44],"evidence":[45],"implicates":[46],"TAAR1-mediated":[47],"regulation":[48],"tone":[51,193],"primary":[54],"circuit":[55,175],"mechanism,":[56],"little":[57],"is":[58],"known":[59],"about":[60],"effects":[62,140],"TAAR1":[64,82,146,180],"agonists":[65],"on":[66,91],"system":[69],"excitation-inhibition":[71,155],"balance.":[72],"Here":[73],"we":[74,150],"assessed":[75],"impact":[77],"ulotaront":[79,117,153,178],"(SEP-363856),":[80],"agonist":[83],"in":[84,94,109,123,134,157],"Phase":[85],"III":[86],"development":[88],"schizophrenia,":[90],"glutamate":[92],"function":[93,198],"mouse":[96],"hippocampus.":[99],"Ulotaront":[100],"reduced":[101],"spontaneous":[102,167],"synaptic":[104,121,168],"transmission":[105,122],"neuronal":[107],"firing":[108],"striatal":[110,139],"hippocampal":[112],"brain":[113,125],"slices,":[114],"respectively.":[115],"Interestingly,":[116],"potentiated":[118],"electrically-evoked":[119],"excitatory":[120],"both":[124,189],"regions,":[126],"suggesting":[127],"ability":[129],"to":[130,187],"modulate":[131],"signaling":[133],"state-dependent":[136],"manner.":[137],"Similar":[138],"were":[141],"also":[142],"observed":[143],"agonist,":[147],"RO5166017.":[148],"Furthermore,":[149],"show":[151],"that":[152],"regulates":[154],"balance":[156],"specifically":[161],"modulating":[162],"glutamatergic,":[163],"but":[164],"not":[165],"GABAergic,":[166],"events.":[169],"These":[170],"findings":[171],"expand":[172],"mechanistic":[174],"hypothesis":[176],"agonists,":[181],"which":[182],"may":[183],"be":[184],"uniquely":[185],"positioned":[186],"normalize":[188],"excessive":[191],"regulate":[195],"abnormal":[196]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-12-20T00:00:00"}